The Predicting Effect of ASXL1 Mutation on BCR-ABL Transcript Types and Responses to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia. mfm 2025, 36 (8). https://doi.org/10.60110/medforum.360805.